phosphorus has been researched along with Dyslipidemias in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Singh, A; Tandon, C; Tandon, S | 1 |
Bostom, A; Ix, JH; Rao, M; Steffes, M | 1 |
Escobar-Jiménez, F; García-Castro, JM; García-Martín, A; Muñoz-Torres, M; Quesada-Charneco, M; Reyes-García, R | 1 |
Bostom, AG; Hanlon, WA; Kuznetsova, O; Maccubbin, D; Tipping, D | 1 |
Bostom, AG; Harris, WS; Hu, S; Shearer, GC; Steffes, MW | 1 |
Aniort, J; Deteix, P; Garrouste, C; Hadj Abdelkader, M; Heng, AE; Kaysi, S; Philipponnet, C | 1 |
Ammirati, AL; Cendoroglo, M; Dalboni, MA; Draibe, SA; Fernandes Canziani, ME | 1 |
1 review(s) available for phosphorus and Dyslipidemias
Article | Year |
---|---|
An update on vascular calcification and potential therapeutics.
Topics: Atherosclerosis; Calcimimetic Agents; Calcium; Denosumab; Diabetes Mellitus; Diphosphonates; Dyslipidemias; Enzyme Inhibitors; Homeostasis; Hypertension; Inositol Phosphates; Phosphorus; Renal Insufficiency, Chronic; Thiosulfates; Vascular Calcification; Vitamin D; Vitamin K | 2021 |
3 trial(s) available for phosphorus and Dyslipidemias
Article | Year |
---|---|
Effect of niacin on FGF23 concentration in chronic kidney disease.
Topics: Aged; Calcium; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Niacin; Parathyroid Hormone; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Renal Insufficiency, Chronic | 2014 |
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
Topics: Aged; Biomarkers; Calcium; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Diseases; Male; Middle Aged; Niacin; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Time Factors | 2010 |
Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia.
Topics: Calcium; Delayed-Action Preparations; Drug Administration Schedule; Dyslipidemias; Glomerular Filtration Rate; Humans; Hypolipidemic Agents; Metabolic Syndrome; Niacin; Phosphorus; Serum Albumin | 2011 |
3 other study(ies) available for phosphorus and Dyslipidemias
Article | Year |
---|---|
Cardiovascular risk factors in patients with asymptomatic primary hyperparathyroidism.
Topics: Adult; Aged; Asymptomatic Diseases; Body Mass Index; Calcium; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Dyslipidemias; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Hypertension; Male; Middle Aged; Obesity; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Retrospective Studies; Risk Factors | 2014 |
Chronic renal failure complications and management in kidney transplanted and nontransplanted patients.
Topics: Anemia; Biomarkers; Blood Pressure; Chi-Square Distribution; Dyslipidemias; Ferritins; Guideline Adherence; Humans; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Outcome and Process Assessment, Health Care; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2012 |
Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; C-Reactive Protein; Calcinosis; Calcium; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Humans; Hypertension; Inflammation; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Tomography, X-Ray Computed | 2006 |